Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses FRESH-PEF73441-en Florence CARROUEL Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses BBCovid FRESH-PEF73441-en 73441 FRESH-PEF73441 Florence CARROUEL UNIVERSITE CLAUDE BERNARD LYON 1 Epidemiology France Portal (PEF) null Florence;CARROUEL Infectious disease medicine Certain infectious or parasitic diseases COVID-19 Change from Baseline amount of SARS-CoV-2 in salivary samples at 7 days Quantitative PCR experiments will be performed and a quantitative analysis of the salivary samples will be made null France Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) • Age: 18-70 years • Clinical diagnosis of Covid-19 infection by the patient's general practitioner and hospital doctor • Clinical signs started less than 48 hours ago. • Virological confirmation: not necessary but possible. • Understanding and acceptance of the trial. • Written agreement to participate in the trial Clinical data Biological data Other < 500 individuals Converting or copying information into a structured record Observational Study Observational Study Unknown To be defined